Schedule 13G ownership disclosure
SIO GENE THERAPIES INC
Security class unavailable · CUSIP: 829399104
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,000,000
- Percent of class
- 9.4600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-018477
- Form type
- SC 13G
- Filer
- Rubric Capital Management LP
- CIK
- CIK 1687509
- Filed
- Feb 10, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership